APA

Kröger N., Schetelig J., Zabelina T., Krüger W., Renges H., Stute N., Schrum J., Kabisch H., Siegert W. & Zander A. R. (20011214). A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. : Bone marrow transplantation.

Chicago

Kröger N, Schetelig J, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W and Zander A R. 20011214. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. : Bone marrow transplantation.

Harvard

Kröger N., Schetelig J., Zabelina T., Krüger W., Renges H., Stute N., Schrum J., Kabisch H., Siegert W. and Zander A. R. (20011214). A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. : Bone marrow transplantation.

MLA

Kröger N, Schetelig J, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W and Zander A R. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. : Bone marrow transplantation. 20011214.